Expert faculty members summarize key viral hepatitis studies from this important annual conference. Use these slides to review data on newer HCV regimens, the HCV continuum of care, posttreatment HCV outcomes, HCV D+R- transplantation, NA cessation in chronic hepatitis B, and investigational HBV/HDV therapeutics.
Listen to downloadable audio from a live Webinar by Jordan J. Feld, MD, MPH, in which the clinical impact of new viral hepatitis data reported at the San Francisco meeting is discussed.
Here’s my take on how data presented in San Francisco shed light on where we can improve HBV care.
Expert faculty summarize key NAFLD/NASH studies from this important annual conference. Use these slides to review data on noninvasive screening, clinical outcomes, emerging treatments.
Listen to downloadable audio from a live Webinar by Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, in which the clinical impact of new NAFLD/NASH data reported at the San Francisco meeting are discussed.
Here’s my take on where we are heading in assessing NASH endpoints in clinical trials.
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.